Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 511

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 511
---
 and per share amounts)

    As of December 31,

    2024

    2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    1,103,010

    $
    428,430

    Short-term investments

    251,782

    1,247,820

    Accounts receivable, net

    601,988

    400,327

    Inventory

    749,960

    322,859

    Manufacturing-related deposits and prepaids

    276,262

    102,181

    Other current assets

    90,461

    77,714

    Total current assets

    3,073,463

    2,579,331

    Property and equipment, net

    340,336

    227,154

    Right of use assets

    148,310

    129,952

    Non-current inventory

    187,986

    191,368

    Non-current investments

    133,163

    —

    Other non-current assets

    79,915

    136,771

    Total assets
     
    $
    3,963,173

    $
    3,264,576

    Liabilities and Stockholders’ Equity

    Current liabilities:

    Accounts payable
     
    $
    214,442

    $
    164,918

    Accrued expenses

    373,513

    314,997

    Deferred revenue, current portion

    130,256

    50,416

    Current portion of long-term debt

    —

    105,483

    Other current liabilities

    13,473

    17,845

    Total current liabilities

    731,684

    653,659

    Long-term debt

    1,137,124

    1,132,515

    Lease liabilities, net of current portion

    192,473

    140,965

    Deferred revenue, net of current portion

    325,000

    437,000

    Contingent consideration

    47,400

    38,100

    Other non-current liabilities

    1,750

    3,000

    Total liabilities

    2,435,431